- Home
- NITO vs EVOK Comparison
NITO vs EVOK Comparison
Compare NITO & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NITO
- EVOK
- Stock Information
- Founded
- NITO 2009
- EVOK 2007
- Country
- NITO Israel
- EVOK United States
- Employees
- NITO N/A
- EVOK N/A
- Industry
- NITO
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- NITO
- EVOK Health Care
- Exchange
- NITO NYSE
- EVOK Nasdaq
- Market Cap
- NITO 4.2M
- EVOK 4.2M
- IPO Year
- NITO N/A
- EVOK 2013
- Fundamental
- Price
- NITO $0.30
- EVOK $2.95
- Analyst Decision
- NITO
- EVOK
- Analyst Count
- NITO 0
- EVOK 0
- Target Price
- NITO N/A
- EVOK N/A
- AVG Volume (30 Days)
- NITO 5.6M
- EVOK 14.3K
- Earning Date
- NITO 05-15-2025
- EVOK 05-13-2025
- Dividend Yield
- NITO N/A
- EVOK N/A
- EPS Growth
- NITO N/A
- EVOK N/A
- EPS
- NITO N/A
- EVOK N/A
- Revenue
- NITO $232,000.00
- EVOK $11,594,083.00
- Revenue This Year
- NITO N/A
- EVOK $57.82
- Revenue Next Year
- NITO N/A
- EVOK $59.12
- P/E Ratio
- NITO N/A
- EVOK N/A
- Revenue Growth
- NITO 24.74
- EVOK 89.89
- 52 Week Low
- NITO $0.16
- EVOK $1.94
- 52 Week High
- NITO $3.49
- EVOK $12.32
- Technical
- Relative Strength Index (RSI)
- NITO 49.96
- EVOK 38.86
- Support Level
- NITO $0.25
- EVOK $3.33
- Resistance Level
- NITO $0.30
- EVOK $3.66
- Average True Range (ATR)
- NITO 0.03
- EVOK 0.29
- MACD
- NITO -0.00
- EVOK -0.06
- Stochastic Oscillator
- NITO 67.66
- EVOK 2.99
About NITO N2OFF INC
N2OFF Inc is a pioneering agri-food tech company dedicated to developing sustainable solutions for the plant-based food industry. Operating through two subsidiaries, it delivers integrated solutions for enhanced safety, quality, and sustainability from field to fork. The Company has two reportable segments: Pathogen prevention and prolong shelf life, and the N2O emissions Global warming solutions.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.